David T. Luyimbazi
David T. Luyimbazi publishes mostly in Molecular Biology, Oncology and Surgery, on topics such as PI3K/AKT/mTOR signaling in cancer, Cancer Treatment and Pharmacology and Cancer, Lipids, and Metabolism.
- World rank
- #3,231,495 of 7,710,434 ranked researchers
- Rank in United States
- #916,738 of 1,627,098
- Works
- 30
- Citations
- 553
- Citations per work
- 18.4
What does David T. Luyimbazi research?
David T. Luyimbazi's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (25%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1240.3%
- Medicine1240.3%
- Everything else1034.3%
- Life Sciences825.4%
- 1Molecular Biology21% of their works
- 2Oncology16% of their works
- 3Surgery13% of their works
- 4Hepatology6% of their works
- 5Cancer Research4% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
Which keywords describe David T. Luyimbazi's research?
The keywords of their largest research topics: Cancer, Metabolism, mTOR, Signaling, Clinical Practice Guidelines, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and Blood-Brain Barrier.
- Inflammation
- Cyclooxygenase-2 Inhibitors
- Biogenic Amines
- Lipid Metabolism
- Focused Ultrasound
- Blood-Brain Barrier
- Chemotherapy-Induced Peripheral Neuropathy
- mTOR
- Metabolism
- Cancer
- Signaling
- Clinical Practice Guidelines
- Taxanes
- Fatty Acid Synthase
- Hepatocellular Carcinoma
- Liver Cancer
- Chemotherapy
- Gastric Cancer
- Polyamines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cancer144 topics
- Metabolism92 topics
- Signaling71 topic
- mTOR71 topic
- Clinical Practice Guidelines52 topics
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Taxanes41 topic
- Blood-Brain Barrier31 topic
- Fatty Acid Synthase31 topic
- Focused Ultrasound31 topic
- Hepatocellular Carcinoma31 topic
- Lipid Metabolism31 topic
- Liver Cancer31 topic
- Biogenic Amines21 topic
- Chemotherapy21 topic
- Cyclooxygenase-2 Inhibitors21 topic
- Gastric Cancer21 topic
- Inflammation21 topic
- Polyamines21 topic
Where does David T. Luyimbazi work?
David T. Luyimbazi's main affiliation in the publication record is Carilion Clinic, United States.
How many publications and citations does David T. Luyimbazi have?
OpenAlex counts 30 works and 553 citations for David T. Luyimbazi, an h-index of 12, ranking #3,231,495 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David T. Luyimbazi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.